Determinants of variability of five programmed death ligand-1 immunohistochemistry assays in non-small cell lung cancer samples

Programmed death ligand-1 (PD-L1) expression as determined by immunohistochemistry (IHC) is potentially predictive of clinical outcome. The aim of this study was to assess the concordance of reported PD-L1 IHC assays and investigate factors influencing variability. Consecutive sections from 20 non-s...

Descripción completa

Detalles Bibliográficos
Autores principales: Soo, Ross A., Yun Lim, Joey Sze, Asuncion, Bernadette Reyna, Fazreen, Zul, Herrera, Maria Cynthia, Mohd Omar, Mohd Feroz, Diem Phuong, Nguyen Hoang, Seet, Ju Ee, Amanuel, Benhur, Iacopetta, Barry, Byrne, David, Hendry, Shona, Fox, Stephen, Soong, Richie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5805519/
https://www.ncbi.nlm.nih.gov/pubmed/29467933
http://dx.doi.org/10.18632/oncotarget.23827

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5805519/
https://www.ncbi.nlm.nih.gov/pubmed/29467933
http://dx.doi.org/10.18632/oncotarget.23827

Ejemplares similares